Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York...
Monday, May 2, 2022 BiopharmaWatch Research 1 min read
Key Takeaway: This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48-hrs after the live webcast.
SOURCE Johnson & Johnson
21 %
Price reaction · baseline $180.46 (2022-04-29 close) · clean, no other JNJ news in the window
day 0 close · peak
-1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48-hrs after the live webcast.